Catalyst Wire Dossier Catalyst Wire Dossier

Bifidobacterium lactis HN019

Bifidobacterium lactis HN019 · Fonterra Research Centre
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bifidobacterium lactis HN019, covering 2010-07-28 to 2010-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults [Phase 3]

See pricing